Citation

Bartok V. Pharm Times 2014; 80(1).

Copyright

(Copyright © 2014, Pharmacy Times)

DOI

unavailable

PMID

unavailable

Abstract

[Abstract unavailable]

Language: en

Keywords

disability; human; male; prognosis; aged; case report; quality of life; exercise; depression; joint stiffness; suicide attempt; social isolation; inflammation; risk factor; article; cholesterol blood level; clinical feature; vaccination; headache; practice guideline; paracetamol; cholesterol; rheumatoid arthritis; nonsteroid antiinflammatory agent; diarrhea; nausea; drug withdrawal; diphenhydramine; fever; anamnesis; corticosteroid; erythema; hypertension; infection; physiotherapy; arthralgia; pruritus; alanine aminotransferase; risk reduction; dyspnea; walking; neoplasm; azathioprine; occupational therapy; pneumonia; blood pressure; urticaria; hepatitis B vaccine; unspecified side effect; urinary tract infection; liver disease; minocycline; disease activity; methotrexate; chill; drug induced headache; injection site reaction; injection site pain; alanine aminotransferase blood level; upper respiratory tract infection; cyclosporin; infliximab; diet therapy; respiratory tract infection; etanercept; sore throat; adalimumab; hydroxychloroquine; disease modifying antirheumatic drug; leflunomide; salazosulfapyridine; skin infection; rhinopharyngitis; rituximab; corticosteroid therapy; influenza vaccine; Wart virus vaccine; golimumab; biological response modifier; certolizumab pegol; swelling; Pneumococcus vaccine; rest; recombinant interleukin 1 receptor blocking agent; varicella zoster vaccine; abatacept; tocilizumab; rheumatoid vasculitis; rheumatology; tofacitinib